Abstract:Objective To study C-X3-C chemokine ligand 1 (CX3CL1) in plasma or cerebrospinal fluid whether could be used as an biomaker of central nervous system infection.Methods The plasma and CSF samples were collected from neonates who were suspected to have central nervous infection with lumbar puncture check admitted to Neonatal Ward of Children's Hospital of Fudan University from December 2015 to May 2016,and they set for infection group,according to clinical manifestations,cerebrospinal fluid routine,biochemistry and culture results,they were divided into the central infection,sepsis and non-sepsis groups.At the same period healthy newborns cord blood samples were collected in the maternity ward of Obstetrics and Gynecology Hospital of Fudan University as a normal control group,and on the basis of birth weight group was divided into ＜ 2 000 g,-2 500 g,-3 000 g,-3 500 g,＞3 500 g groups;and according to gestational age divided into ＜ 33 w,-35 w,-37 w,-39 w,＞39 w groups.Using Luminex technology to detect CX3CL1 protein levels (Milliplex reagent kit HCYTOMAG-60K-06),the differences between groups and subgroups were compared.Results In 69 cases of control group,there were 24 cases wit hinfection.There were 8 cases in central infection group (meningitis),10 cases in sepsis group and 6 cases in non-sepsis subgroup (1 case with urinary tract infection,2 cases with neonatal convulsion,1 case with hyperbilirubinemia and esophageal tracheal fistula).In the control group,CX3CL1 in cord blood was (97.8+.13.3) pg · mL-1,there was no significant difference in cord blood CX3CL1 level among different body weight subgroups and different gestational weeks subgroups (P＞0.05).In infection group plasma CX3CL1 level [(95.1±8.2)pg · mL-1] had no significant difference from control group(t=-1.045,P=0.299).There was significant difference in CX3CL1 level between plasma and cerebrospinal fluid,CX3CL1 level was significantly higher in cerebrospinal fluid(210.0 ± 11.9) pg · mL-1 (P ＜ 0.001).Among central infection group,sepsis group and non-sepsis group cerebrospinal fluid CX3CL1 levels (243.1 ± 13.3) pg · mL-1,(208.2 ± 20.1) pg · mL-1 and (168.7 ± 20.6) pg · mL-1,there were significant differences (P=0.046);There were also significant differences in CX3CL1 levels in cerebrospinal fluid between central infection group and non-sepsis group (P =0.016);There were no significant differences in CX3CL1 levels in cerebrospinal fluid between central infection group and sepsis group (P =0.180) or between sepsis group and non-sepsis group (P =0.169).Conclus1on CX3CL1 level in plasma is relatively stable in the healthy newborns,CX3CL1 level in plasma can not be used to diagnose central nervous infection,CSF CX3CL1 levels may be an auxiliary biomarker for diagnosis of central nervous infection and its severity.

The Relationship Between the Granulocyte-Stimulating Factor Level and White Blood Cell in the Cord Blood of Full Term Newborns

Predictive significance of neutrophil-to-lymphocyte and platelet-to-lymphocyte for cytomegalovirus infection in infants less than 3 months: A retrospective study

Investigation on related factors of CD 34+ cells in peripheral blood mobilization effect by G-SCF stimulation

Neutrophil CD11b Expression in Healthy Neonates

Correlation of monocyte counts prior to the collection of recombinant human granulocyte colony-stimulating factor primed bone marrow grafts with the quantities of CD34~+ cells in the grafts.

[CD34 Cells and T Cell Subsets in Recombinant Human Granulocyte Colony-Stimulating Factor Primed Bone Marrow Grafts from Donors with Different Characteristics].

Influence of Recombinant Human Granulocyte Colony Stimulating Factor (Rhg-Csf) on CD34+ Hematopoietic Stem Cells and Regulatory T Cells in Healthy Donors

Evaluation of serum granulocyte colony stimulating factor levels in infants of preeclamptic mothers

Detection of the serum drug levels in children with acute leukemia before and after repeated administration of rhG-CSF and its clinical significance

Influence of maternal and infant factors on CD34+ hematopoietic stem/progenitor cells in umbilical cord blood

Quantitative estimation of G-CSFR expressed on nucleated cells in peripheral blood from healthy people

Study on the correlation between CX3CL1 and neonatal central nervous system infection

A comparison of hematopoietic and immunological characteristics of granulocyte colony-stimulating factor primed bone marrow grafts between pediatric and adult donors

Basal CD34+ Cell Count Predicts Peripheral Blood Stem Cell Mobilization in Healthy Donors after Administration of Granulocyte Colony-Stimulating Factor: A Longitudinal, Prospective, Observational, Single-Center, Cohort Study

Expression of Peripheral Blood Neutrophil CD64 in Neonatal Septicemia

LOCALIZATION OF GRANULOCYTE-MONOCYTE AND GRANULOCYTE COLONY-STIMULATING FACTORS IN HUMAN PLACENTAL TROPHOBLASTIC CELLS

Factors modulating circulation of hematopoietic progenitor cells in cord blood and neonates

The Differences Between Recombinant Human Granulocyte Colony-Stimulating Factor-Primed and Nonprimed Peripheral Blood Stem Cell Harvests

Effects of rhG-CSF mobilization on immunological characteristics of peripheral blood grafts and steady-state bone marrow

Model analysis of the contrasting effects of GM‐CSF and G‐CSF treatment on peripheral blood neutrophils observed in three patients with childhood‐onset cyclic neutropenia

Application of G-CSF in high-leukocyte acute myeloid leukemia is a poor prognostic factor